SYNRIBO*
Manufacturer Details
GENERIC*
USA AND CANADA
Compositions:
Omacetaxine mepesuccinate -mg,
|
Strength
|
Rate
|
Packing Style
|
|
mg
|
0.00
|
unit
|
List of Related Indications:
- To treat adults with chronic myelogenous leukemia (CML) a blood and bone marrow disease
List Of Drugs:
- Omacetaxine mepesuccinate - Anti-cancer drug
Indication Type Description:
Indication:
Drug Name- Synribo
Active Ingredient - Omacetaxine mepesuccinate
To treat adults with chronic myelogenous leukemia (CML) , a blood
and bone marrow disease
Indication-
To treat adults with chronic myelogenous leukemia (CML) , a blood
and bone marrow disease
Approved by FDA on 26-10--2012 (Ref- FDA approved List- 2012)
Dosages/ Overdosage Etc:
Indication-
To treat adults with chronic myelogenous leukemia (CML) , a blood
and bone marrow disease
